Nano Mobile Healthcare, Inc. (Form: 3, Received: 06/14/2018 09:36:59)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

FINNEGAN CARA MARIE

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/4/2018

3. Issuer Name and Ticker or Trading Symbol

Nano Mobile Healthcare, Inc. [VNTH]

(Last) (First) (Middle)

514 AMERICAS WAY #7697

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___X___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

BOX ELDER, SD 57719-7600

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.00001	300,000 ⁽¹⁾	I	Trust
Common Stock, par value $0.00001	157,500 ⁽²⁾	I	Trust

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series C Preferred Stock	⁽³⁾	⁽³⁾	Common Stock, par value $0.00001 ⁽⁴⁾	201,460,071	⁽⁵⁾	I	Trust
Series C Preferred Stock	⁽³⁾	⁽³⁾	Common Stock, par value $0.00001 ⁽⁴⁾	483,504,170	⁽⁵⁾	I	Trust

Explanation of Responses:
(1)	The Reporting Person is Trustee of the John E. Groman Irrevocable Trust dated May 20, 2014, and beneficiary of 50% of the Trust's assets.
(2)	The Reporting Person is a 50% beneficiary of the Groman Finnegan Investment Trust under declaration of trust dated 1/18/2002
(3)	The Preferred shares are exercisable when the company has enough common stock to convert the preferred to common.
(4)	Convertible into common stock at the rate of 20,000 shares of common stock for each share of Series C Preferred Stock.
(5)	Series C Preferred Stock is convertible without payment.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
FINNEGAN CARA MARIE 514 AMERICAS WAY #7697 BOX ELDER, SD 57719-7600		X

Signatures
/s/ Cara M. Finnegan		6/14/2018
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.